Answers are grounded in this paper and cite their sources.
Ferrohydrodynamic microfluidics uses magnetic nanoparticles dispersed in ferrofluids to generate magnetic buoyancy forces for continuous manipulation of diamagnetic particles and magnetically labeled cells. These forces enable separation and phenotyping of cells, extracellular vesicles, and other bioparticles across length scales, although downstream molecular and functional compatibility depends on controlling ferrofluid exposure and residual nanoparticles. This Perspective examines the evolution of ferrofluid-based microfluidics from size-based enrichment toward quantitative physical and molecular phenotyping. We assess key technical and translational challenges, including biocompatibility, scalable and reproducible device architectures, nanoparticle depletion, quality control, and clinical translation. We also define application-specific priorities and discuss how engineered ferrofluids, additive manufacturing, machine learning, and molecular readouts could broaden the versatility of these platforms for precision bioanalysis.
No takes yet. Share an insight, caveat, or question.
Teng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: